Jasper Therapeutics
Price & Volume
Stats
See more52W Range | $0.62-$7.19 |
Market Cap | $24.9M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.58 |
News
See moreYahoo Finance • 5 days ago
AZN, Daiichi's Enhertu Gets Positive CHMP Opinion for Solid Tumors
Yahoo Finance • 2 months ago
Evercore ISI Lowers its Price Target on Jasper Therapeutics (JSPR) to $7
Yahoo Finance • 2 months ago
Why UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab
About
CEO | Mr. Jeetinder Singh Mahal M.B.A. |
CFO | Mr. Herbert C. Cross CPA |
Address | 2200 Bridge Pkwy, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 22 |